文献速递主动脉疾病

Cook Zenith Alpha与Medtronic Endurant II患者EVAR术后支架内血栓形成的回顾性评估

A Retrospective Evaluation of Intra-Prosthetic Thrombus Formation After Endovascular Aortic Repair in Cook Zenith Alpha and Medtronic Endurant II Patients.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-06-05

单中心回顾性研究纳入2017至2019年接受Zenith Alpha或Endurant II支架移植的患者,重新评估术后CT血管造影以检测血栓形成。Zenith Alpha组肢体移植物闭塞(LGO)发生率15%显著高于Endurant II组5%,且Zenith Alpha为LGO独立危险因素(OR 3.9)。两组整体肢体支架内血栓(IPT)无差异。

要点

  • Zenith Alpha组LGO发生率15%(n=12) vs Endurant II组5%(n=4),p=0.032
  • Zenith Alpha支架为LGO独立危险因素(OR 3.9,95%CI 1.1-13.4;p=0.032)
  • 两组整体肢体IPT无显著差异

核心结论

  • Zenith Alpha患者LGO显著多于Endurant II患者,Zenith Alpha肢体为LGO独立危险因素,两组整体肢体IPT形成无差异。

研究设计与样本

  • 单中心回顾性研究,纳入2017至2019年接受Zenith Alpha(78例)和Endurant II(86例)支架移植的患者,重新评估术后CT血管造影图像。

主要发现

  • Zenith Alpha组中位随访33个月(IQR 25,44),Endurant II组36个月(IQR 22,46),p=0.53。
  • LGO在Zenith Alpha组为15%(n=12),Endurant II组为5%(n=4),p=0.032;Endurant II组免于LGO显著更高(p=0.024)。
  • Zenith Alpha支架为LGO独立危险因素(OR 3.9,95%CI 1.1-13.4;p=0.032)。
  • Zenith Alpha组中,LGO患者肢体喇叭口压缩于主体门内比例过高(p=0.011)。
  • 两组整体肢体IPT免于发生无差异;Endurant II肢体中,同侧整合肢体(无ETLW/ETEW支架肢体)IPT显著更少见(p=0.044);主体支架IPT与整体肢体IPT相关(p=0.035)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the occurrence of limb graft occlusion (LGO) and intra-prosthetic thrombus (IPT) formation in Zenith Alpha and Endurant II stent graft limbs. METHODS: A single centre retrospective study was conducted on patients treated with the Zenith Alpha and Endurant II stent grafts between 2017 and 2019. All post-operative computed tomography angiography images were re-investigated for thrombus formation. Demographic, aneurysm, and stent graft data were collected and compared. LGO was defined as complete occlusion or significant stenosis (≥ 50% lumen diameter reduction). Logistic regression on pro-thrombotic risk factors was conducted. Freedom from LGO and overall limb IPT were compared using Kaplan-Meier analyses. RESULTS: Seventy-eight Zenith Alpha and eighty-six Endurant II patients were studied. The median follow up was 33 (IQR 25, 44) months for Zenith Alpha patients and 36 (IQR 22, 46) months for Endurant II patients (p = .53). LGO was seen in 15% (n = 12) of Zenith Alpha patients and 5% (n = 4) of Endurant II patients (p = .032), and freedom from LGO was significantly higher among Endurant II patients (p = .024). The Zenith Alpha stent graft was an independent risk factor for LGO (OR 3.9, 95% CI 1.1 - 13.4; p = .032). Among Zenith Alpha patients, limb flare compression within the main body gate was over represented in LGO patients (p = .011). There was no difference in freedom from overall limb IPT between the stent graft systems. For Endurant II limbs, IPT was significantly less common in the integrated ipsilateral limbs (without ETLW/ETEW stent graft limbs) (p = .044). Main endograft body IPT was correlated with overall limb IPT (p = .035). CONCLUSION: LGO was significantly more common among Zenith Alpha than Endurant II patients. Zenith Alpha limbs was an independent risk factor for LGO. There was no difference between stent grafts in overall limb IPT formation.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ulsaker H, Lam M, Herje ML, et al. A Retrospective Evaluation of Intra-Prosthetic Thrombus Formation After Endovascular Aortic Repair in Cook Zenith Alpha and Medtronic Endurant II Patients. Eur J Vasc Endovasc Surg. 2023. PMID: 37286099. doi:10.1016/j.ejvs.2023.05.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。